No Picture
News

Berkeley Lights Debuts in France as MImAbs Acquires the Beacon® Optofluidic System for Antibody Discovery

EMERYVILLE, Calif. and MARSEILLE, France, Dec. 02, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and MImAbs SAS, an emerging CRO that discovers and develops antibodies for immunotechnology therapeutics … […]

No Picture
News

Berkeley Lights announces technology collaboration to accelerate and improve gene therapy viral vector development and manufacturing

EMERYVILLE, Calif., July 21, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI) today announced a strategic collaboration with Thermo Fisher Scientific aimed at addressing challenges in commercial-scale viral vector manufacturing. The partner… […]

No Picture
News

Berkeley Lights to Report Second Quarter 2021 Financial Results on August 11, 2021

EMERYVILLE, Calif., July 13, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the second quarter 2021 before market open on Wednesday, Au… […]

No Picture
News

Berkeley Lights releases subscription-based access program and signs first customers

EMERYVILLE, Calif., June 01, 2021 (GLOBE NEWSWIRE) — Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the release of its TechAccess Subscription model to enable broader customer access to their cutting-edge, sing… […]

No Picture
News

Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets

EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) — Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry’s premier antibody dis… […]